Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2008 | 1 |
2015 | 1 |
2016 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
Int J Cardiol. 2016 Jan 15;203:909-15. doi: 10.1016/j.ijcard.2015.11.060. Epub 2015 Nov 7.
Int J Cardiol. 2016.
PMID: 26618252
Review.
Heart failure is a systemic and multiorgan syndrome with metabolic failure as a fundamental mechanism. ...This review focuses on the rationale and clinical benefits of trimetazidine by acting on cardiac metabolism in heart failu …
Heart failure is a systemic and multiorgan syndrome with metabolic failure as a fundamental mechanism. ...This r …
Current Clinical Evidence of Trimetazidine in the Management of Heart Disease in Patients with Diabetes.
Mahajan S, Mahajan AU.
Mahajan S, et al.
J Assoc Physicians India. 2020 Nov;68(11):46-50.
J Assoc Physicians India. 2020.
PMID: 33187037
Review.
Therefore, there is a need for early and effective treatment intervention for this myocardial cell metabolic dysfunction. DM and myocardial ischemia (MI) share a common metabolic dysregulation mediated via increased fatty acid oxidation that makes the …
Therefore, there is a need for early and effective treatment intervention for this myocardial cell metabolic dysfunction. DM a …
Item in Clipboard
The role of trimetazidine after acute myocardial infarction.
Banach M, Rysz J, Goch A, Mikhailidis DP, Rosano GM.
Banach M, et al.
Curr Vasc Pharmacol. 2008 Oct;6(4):282-91. doi: 10.2174/157016108785909788.
Curr Vasc Pharmacol. 2008.
PMID: 18855716
Review.
Trimetazidine is the most investigated drugs in this group. The ESC 2006 guidelines on the management of patients with stable angina mention the efficacy of metabolic treatment in improving physical efficiency and decreasing the recurrence of pain. ...The mos …
Trimetazidine is the most investigated drugs in this group. The ESC 2006 guidelines on the management of patients with stable …
Item in Clipboard
["Persistent" angina: rationale for a metabolic approach].
Marzilli M.
Marzilli M.
Ital Heart J. 2004 Mar;5 Suppl 2:37S-41S.
Ital Heart J. 2004.
PMID: 15074776
Review.
Italian.
Tailoring therapy to individual needs has become even more challenging because of the marked changes in the clinical profile of patients with chronic ischemic heart disease. Compared with the past, today's patients tend to be older, to have undergone revascularization proc …
Tailoring therapy to individual needs has become even more challenging because of the marked changes in the clinical profile of patients wit …
Item in Clipboard
Cite
Cite